Health & Safety Industry Today
Cell-Free Protein Expression Market to Reach USD 461.43 million by 2030, Driven by Rapid Adoption in Research and High-Throughput Screening
Introduction
The cell-free protein expression market size stands at USD 311.75 million in 2025 and is forecast to reach USD 461.43 million by 2030, reflecting an 8.16% CAGR.
The cell-free protein expression market is growing as researchers adopt faster, more flexible protein production systems that overcome the limitations of traditional cell-based methods. Its demand is increasing across drug discovery, enzyme engineering, structural biology, and high-throughput screening applications.
Growth is also supported by increasing use of recombinant proteins, rising demand for customized protein synthesis, and the need for efficient expression systems that can support complex and toxic proteins. Academic labs, pharmaceutical companies, and biotech innovators are increasingly adopting commercial cell-free kits and reagents to streamline experiments. As a result,
Key Market Trends
- Rise in Cell-free Platforms for On-demand Biologics Manufacturing
- Growth of Personalized & Rapid Vaccine Prototyping
- Increasing Research and Development in Proteomics and Genomics
- Surging Investments in Synthetic Biology Start-ups
- High Upfront Capital for Cell-free Automation Workstations
- Persistent Gap in Large-volume Lysate Supply
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
Market Segmentation
By Products
- Accessories & Consumables
- Lysate Systems
By Expression Method
- Coupled Transcription and Translation
- Translation
By Application
- Enzyme Engineering
- High Throughput Production
- Protein Labeling
- Protein-Protein Interaction Studies
- Vaccine & Therapeutic Development
- Other Applications
By End-User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CROs & CDMOs
- Other End Users
Geography Analysis:
North America continues to lead the space thanks to strong government support, an active biotech investment landscape, and clear regulatory guidance that has encouraged commercial-scale partnerships. In Asia-Pacific, momentum is building rapidly as countries invest in next-gen vaccine infrastructure and adopt policies that favor flexible, fast-turnaround production systems. Europe is progressing steadily as regulators promote modular manufacturing and sustainability-focused practices, prompting broader collaboration and greater interest in cell-free platforms across the region.
Explore Our Full Library of Healthcare Research Industry Reports - https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=Industrytoday.co.uk
Key Players
- The cell-free protein expression market features several prominent players, including Thermo Fisher Scientific Inc., Promega Corporation, Merck KGaA (Sigma-Aldrich), Takara Bio Inc., and New England Biolabs. These companies contribute significantly to technological advancements, product innovation, and the overall competitiveness of the market.
Industry Related Reports:
Competent Cells Market:
Cell-Free DNA Testing Market:
Antibody Production Market:
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals.
For any inquiries or to access the full report, please contact:
https://www.mordorintelligence.com/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
